2 results
Approved WMOCompleted
Valemetostat tosylate may modify epigenetic changes, which plays an important role in the pathogenesis of PTCL. In the ongoing open-label Phase 1 study (DS3201-A-J101, 25 Dec 2019 data cut-off), valemetostat tosylate monotherapy demonstrated…
Approved WMOCompleted
To investigate the potential of the Checkpoint Cardio system in the early detection of signals that can predict and warn for an allergic reaction.